PITTSBURGH, April 29 Mylan Inc. (NYSE: MYL)today announced the appointment of Michael J. Monroe as senior vice president- Global Public Affairs and as a member of the company's senior leadershipteam. In this role, Monroe is responsible globally for executive, financialand employee communications; corporate branding/marketing; corporate mediarelations; Internet management, sponsorships and event planning. In addition,he oversees the strategic coordination of communications for the company,working closely with Mylan's operating and support units.
"Mike is a talented and experienced senior executive," said Mylan's ViceChairman and CEO Robert J. Coury. "His broad-based background andunderstanding of international public affairs will serve Mylan well as westrengthen our strategic global communications activities. We are fortunate tohave added someone of Mike's caliber to Mylan's senior leadership team."
Monroe served previously as executive vice president - Public Affairs andchief communications officer for KeyCorp, one of the nation's largestfinancial services companies. During his 30 year career, he also completedassignments of increasing responsibility at CIGNA Corporation, The AmericanExpress Company and AT&T Long Lines Division.
Monroe earned a bachelor's degree from Rutgers University, graduatingmagna cum laude. He also holds a master's degree in journalism from ColumbiaUniversity.
He is a member of The Phi Beta Kappa Society, The Public Relations Seminarand The Wisemen. He has chaired the Public Affairs Council of The FinancialServices Roundtable and is the former chair of The Conference Board'sCommunications Council.
Mylan Inc., with operations in more than 90 countries, ranks among theleading diversified generic and specialty pharmaceutical companies in theworld. The company maintains one of the industry's broadest - and highestquality - product portfolios, supported by a robust product pipeline; owns acontrolling interest in the world's second largest active pharmaceuticalingredient manufacturer; and operates a specialty business focused onrespiratory and allergy therapies.
SOURCE Mylan Inc.